Share on StockTwits

Shares of BTG plc (LON:BTG) have received an average recommendation of “Hold” from the ten brokerages that are covering the stock, American Banking and Market News reports. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is GBX 536.25 ($9.13).

A number of analysts have recently weighed in on BTG shares. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of BTG plc in a research note on Tuesday. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of BTG plc in a research note on Thursday, June 5th. They now have a GBX 525 ($8.94) price target on the stock.

Shares of BTG plc (LON:BTG) opened at 630.50 on Tuesday. BTG plc has a 52-week low of GBX 363.00 and a 52-week high of GBX 643.50. The stock’s 50-day moving average is GBX 579.9 and its 200-day moving average is GBX 574.3. The company’s market cap is £2.275 billion.

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.